2025 annual financial data
Vivos Therapeutics 2025 Operating margin
Vivos Therapeutics 2025 operating margin with verified reported values.
Direct answer
Operating margin was -114.05%.
Operating income was -19,894,000 USD and net income was -21,230,000 USD.
Operating cash flow was -15,263,000 USD.
Get free Vivos Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 17,443,000 USD
- Operating income
- -19,894,000 USD
- Net income
- -21,230,000 USD
- Operating cash flow
- -15,263,000 USD